AMGEN INC is 22.3x more valuable than BIO-TECHNE Corp by market capitalization ($183.41 B vs $8.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TECH | AMGN |
|---|---|---|
| Market cap | $8.22 B | $183.41 B |
| US-listed rank | #1055 | #79 |
| Revenue (latest FY) | $1.22B | $36.75B |
| Net income (latest FY) | $73.40M | $7.71B |
| Net margin | 6.0% | 21.0% |
| P/E (trailing FY) | 112.0 | 23.8 |
| SEC filings | 1,229 | 1,011 |
AMGEN INC is 22.3x more valuable than BIO-TECHNE Corp by market capitalization ($183.41 B vs $8.22 B).
In their latest fiscal years, BIO-TECHNE Corp reported $1.22B in revenue while AMGEN INC reported $36.75B.
Full pages: BIO-TECHNE Corp and AMGEN INC, or browse the full rankings.